A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System

被引:2
|
作者
Holers, V. Michael [1 ]
La Rosa, Francisco G. [2 ]
Banda, Nirmal K. [1 ]
机构
[1] Univ Colorado, Sch Med, Div Rheumatol, Anschutz Med Campus,1775 Aurora Court, Aurora, CO 80045 USA
[2] Univ Colorado, Sch Med, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
Axial spondyloarthritis; Arthritis; Complement; ANTIBODY-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISEASE; HLA-B27; COLLAGEN; ACTIVATION; SERUM; MICE; SPONDYLITIS; DEFICIENCY;
D O I
10.4110/in.2021.21.e45
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many mouse models of rheumatoid arthritis have been identified, but only a limited number are present for axial spondyloarthritis (AxSpA). Collagen Ab-induced arthritis (CAIA) is one of the most widely used mouse models of arthritis, and it is complement-dependent. We found that mice developing CAIA also developed spinal lesions similar to those found in AxSpA. To induce CAIA, mice were injected intraperitoneally at day 0 with anti-collagen Abs, followed by LPS injection at day 3. CAIA mice demonstrated a significant kyphosis through the spine, as well as hypertrophic cartilage and osseous damage of the intravertebral joints. Immunohistochemical staining of the kyphotic area revealed increased complement C3 deposition and macrophage infiltration, with localization to the intravertebral joint margins. Near Infrared (NIR) in vivo imaging showed that anti-collagen Abs conjugated with IRDye (R) 800CW not only localized to cartilage surface in the joints but also to the spine in arthritic mice. We report here a novel preclinical mouse model in which, associated with the induction of CAIA, mice also exhibited salient features of AxSpA; this new experimental model of AxSpA may allow investigators to shed light on the local causal mechanisms of AxSpA bone and soft tissue changes as well as treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
    Barbora Šumová
    Lucie Andrés Cerezo
    Hana Hulejová
    Klára Prajzlerová
    Michal Tomčík
    Kristýna Bubová
    Jan Štěpán
    Mária Filková
    Tereza Kropáčková
    Mariam Grigorian
    Karel Pavelka
    Jiří Vencovský
    Ladislav Šenolt
    BMC Rheumatology, 4
  • [32] Behavioral and pharmacological assessment of a potential new mouse model for mania
    Scotti, Melissa-Ann L.
    Lee, Grace
    Stevenson, Sharon A.
    Ostromecki, Alexandra M.
    Wied, Tyler J.
    Kula, Daniel J.
    Gessay, Griffin M.
    Gammie, Stephen C.
    PHYSIOLOGY & BEHAVIOR, 2011, 103 (3-4) : 376 - 383
  • [33] Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria
    Proft, Fabian
    Poddubnyy, Denis
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (5-6) : 129 - 139
  • [34] Looking Into the New ASAS Classification Criteria for Axial Spondyloarthritis Through the Other Side of the Glass
    Akkoc, Nurullah
    Khan, Muhammad A.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (06)
  • [35] Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid
    Giang, Jenny
    van Doorn, Martijn B. A.
    Diercks, Gilles F. H.
    de Cordoba, Santiago Rodriguez
    van den Bosch, Thierry P. P.
    Schreurs, Marco W. J.
    Poppelaars, Felix
    Damman, Jeffrey
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (05) : 632 - 640
  • [36] New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT
    Diekhoff, Torsten
    Poddubnyy, Denis
    Proft, Fabian
    Ziegeler, Katharina
    Deppe, Dominik
    Niedermeier, Christoph
    Hermann, Kay Geert A.
    RHEUMATOLOGY, 2023, 62 (12) : 3893 - 3898
  • [37] Low bone mineral density predicts the formation of new syndesmophytes in patients with axial spondyloarthritis
    Kim, Hyoung Rae
    Hong, Yeon Sik
    Park, Sung-Hwan
    Ju, Ji Hyeon
    Kang, Kwi Young
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [38] New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents
    Toussirot, Eric
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (03) : 275 - 282
  • [39] Looking Into the New ASAS Classification Criteria for Axial Spondyloarthritis Through the Other Side of the Glass
    Nurullah Akkoc
    Muhammad A. Khan
    Current Rheumatology Reports, 2015, 17
  • [40] Progressive improvement in time to diagnosis in axial spondyloarthritis through an integrated referral and education system
    Chan, Antoni
    Rigler, Kathryn
    Ahmad, Nadia
    Lafont, Tanguy
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (04)